RECRUITING

A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.

Official Title

A Randomized Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Quick Facts

Study Start:2018-09-28
Study Completion:2027-01-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03667599

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness
  2. * Age 18-80 years
  3. * Karnofsky Performance Scale KPS\> 80
  4. * Able to read/write English
  5. * A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke
  1. * Lack of a caregiver
  2. * Pregnant women
  3. * Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection.
  4. * Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota

Contacts and Locations

Study Contact

Andrea Pires, MS
CONTACT
919-613-1546
andrea.pires@duke.edu

Principal Investigator

Anthony Sung, MD
PRINCIPAL_INVESTIGATOR
Duke Health
Nelson Chao, MD
PRINCIPAL_INVESTIGATOR
Duke Health

Study Locations (Sites)

Duke University Medical Center
Durham, North Carolina, 27705
United States

Collaborators and Investigators

Sponsor: Duke University

  • Anthony Sung, MD, PRINCIPAL_INVESTIGATOR, Duke Health
  • Nelson Chao, MD, PRINCIPAL_INVESTIGATOR, Duke Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-09-28
Study Completion Date2027-01-30

Study Record Updates

Study Start Date2018-09-28
Study Completion Date2027-01-30

Terms related to this study

Additional Relevant MeSH Terms

  • Well-being of Caregivers (Caregiver Strain Index)